Back
Humana, Inc. 10K Form
Sell
16
HUM
Humana, Inc.
Last Price:
$184.10
Seasonality Move:
-1.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-24 | 10Q | HUM/Humana, Inc. Quarterly |
| 2024-02-15 | 10K | HUM/Humana, Inc. Annual |
| 2023-11-01 | 10Q | HUM/Humana, Inc. Quarterly |
| 2023-08-02 | 10Q | HUM/Humana, Inc. Quarterly |
| 2023-04-26 | 10Q | HUM/Humana, Inc. Quarterly |
| 2023-02-16 | 10K | HUM/Humana, Inc. Annual |
Receive HUM News And Ratings
See the #1 stock for the next 7 days that we like better than HUM
HUM Financial Statistics
Sales & Book Value
| Annual Sales: | $129.7B |
|---|---|
| Cash Flow: | $-2.1B |
| Price / Cash Flow: | 143.32 |
| Annual Sales: | $146.42 |
| Price / Book: | 1.25 |
Profitability
| EPS (TTM): | 9.80830 |
|---|---|
| Net Income (TTM): | $1.2B |
| Gross Margin: | $0 |
| Return on Equity: | 6.77% |
| Return on Assets: | 2.44% |
Humana, Inc. Earnings Forecast
Key Humana, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for HUM is 0.00%.
-
The Selling, General & Administrative Expenses for HUM have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 52.45% of Operating Income.
-
The Net Earning history of HUM is 0.93% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 25 years.
Humana, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | HUM |
| CUSIP: | 444859 |
| Website: | humana.com |
Debt
| Debt-to-Equity Ratio: | 0.7 |
|---|---|
| Current Ratio: | 2 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.71 |
|---|---|
| Forward P/E Ratio: | 11.28 |
HUM Technical Analysis vs Fundamental Analysis
Sell
16
Humana, Inc. (HUM)
is a Sell
Is Humana, Inc. a Buy or a Sell?
-
Humana, Inc. stock is rated a SellThe current Humana, Inc. [HUM] share price is $184.10. The Score for HUM is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.